Status:
COMPLETED
Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis
Lead Sponsor:
Galderma R&D
Conditions:
Psoriasis
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The primary objectives of this study are to evaluate the safety \& efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.
Detailed Description
Same as above.
Eligibility Criteria
Inclusion
- Diagnosis of moderate to severe plaque psoriasis, defined as 3% - 20% treatable body surface area
- Overall Disease Severity of at least 3 (moderate)
Exclusion
- Surface area involvement too large (\>20% BSA)
- Psoriasis involving only the scalp, groin, axillae, and/or other intertriginous areas
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
305 Patients enrolled
Trial Details
Trial ID
NCT00658788
Start Date
March 1 2008
End Date
January 1 2009
Last Update
August 23 2022
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Therapeutics Clinical Research
San Diego, California, United States, 92123
2
MedaPhase, Inc.
Newnan, Georgia, United States, 30263
3
Gwinnett Clinical Research Center, Inc
Snellville, Georgia, United States, 30078
4
Hudson Dermatology
Evansville, Indiana, United States, 47714